Overview
SLBT market data
Price History
SLBT price chart · 1M
- O
- 2.59
- H
- 2.61
- L
- 2.59
- C
- 2.61
- Vol
- 254.00
- Source
- US equities market feed
- Observed
- Aug 27, 2026, 12:00 AM
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $2.59
- Previous Close
- $2.63
- Day High
- $2.61
- Day Low
- $2.59
- 52 Week High
- $14.43
- 52 Week Low
- $2.59
- 7 Day Return
- -5.09%
- 30 Day Return
- -5.95%
- 90 Day Return
- -75.26%
- 1 Year Return
- -68.93%
- Daily Notional Volume
- $662.9 Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- 840.05 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $0.20 Diluted earnings per share over the trailing twelve months.
- Beta
- 6.74 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $2.54 – $14.50 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $1.5B.
Company News
SL Science Highlighted The Filing Of A New Drug Master File With The U.S. FDA Covering Exosomes Derived From Gamma Delta T CellsBenzinga · Aug 27, 2026, 12:19 PM
SL Science Highlights New FDA Drug Master File For GDT Cell-Derived ExosomesBenzinga · Aug 27, 2026, 12:08 PM
SL Science Announces Publication Of Peer-Reviewed Article In 'Biomedicines' Outlining A Rigorous Development Framework For γδ T Cell Therapy In GlioblastomaBenzinga · Aug 11, 2026, 12:02 PM
SL Science Presents Benefits Of Gamma Delta T Cells In Eliminating Glioblastoma In Preclinical Studies At The 2026 World Congress Of Basic And Clinical PharmacologyBenzinga · Jul 17, 2026, 12:08 PM
Ericsson, Q32 Bio And Other Big Stocks Moving Lower In Tuesday’s Pre-Market SessionBenzinga · Jul 14, 2026, 12:03 PM
SL Science Submits Orphan Drug Designation Request To FDA For Gamma Delta T Cell Therapy Product, Vdelta2+ Gamma Delta T Cells, For Treatment Of Glioblastoma MultiformeBenzinga · Jul 10, 2026, 12:05 PM
Datadog, EHang Holdings And Other Big Stocks Moving Lower In Monday’s Pre-Market SessionBenzinga · Jul 6, 2026, 12:05 PM
Nike, Shutterstock And Other Big Stocks Moving Lower In Wednesday’s Pre-Market SessionBenzinga · Jul 1, 2026, 12:05 PM
ON Semiconductor, SanDisk And Other Big Stocks Moving Lower In Friday’s Pre-Market SessionBenzinga · Jun 26, 2026, 12:10 PM
SL Science Holding, Alamos Gold And Other Big Stocks Moving Lower In Monday’s Pre-Market SessionBenzinga · Jun 22, 2026, 12:05 PM